RE:RE:RE:RE:RE:RE:RE:Feb 24, 2017 Pulmonary Fibrosis News IPF - ProMetic barcodewhiz wrote:
I merely queried whether they considered keeping the mono and combo 1 therapy patients on the drug , given the fairly impressive results.
They will be keeping the people on the combinations as well. The more options with 4050 in it, is a better chance of success. Pretty sure he's on OFEV+4050 cause he was already taking OFEV
I haven't been in contact recently. They have been invited into the next trial, and so long as the trial is open he will have access to the drug (I think).